ARCHIVES

Two Second-Line CML Drugs Work Front-Line, Studies Find

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

March 8, 1991

AACR President Kripke Calls For Dedicated Translational Research

March 11, 1994

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010